NCT05786300

Brief Summary

The goal of this clinical trial is to analyze the effect of the electrical stimulation superimposed onto movement in healthy semi-professional athletes who sustained a type 3a/3b hamstring strain injury. The main questions it aims to answer are:

  • Is NMES+ useful for the treatment of type 3a/3b hamstring strain injury?
  • Does NMES+ improve the quality of the injured muscle tissue? Participants will follow a 3 week protocol, following the latest evidence available.\[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

March 27, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 26, 2023

Status Verified

September 1, 2023

Enrollment Period

10 months

First QC Date

March 1, 2023

Last Update Submit

September 25, 2023

Conditions

Keywords

Electrical Muscle Stimulation (EMS)NMES+Hamstring strain injuryNeuromuscular Electrical Stimulation (NMES)

Outcome Measures

Primary Outcomes (2)

  • Tear monitoring and muscle quality

    Healing status of the muscle tear (mm/cm), using ultrasounds

    Baseline

  • Tear Monitoring

    Healing status of the muscle tear (mm/cm), using ultrasounds

    Up to 6 weeks

Study Arms (2)

Treatment Group

EXPERIMENTAL

The Treatment Group will follow the rehabilitation protocol with the addition of the Neuromuscular Electrical Stimulation Superimposed onto Movement (NMES+) as part of the rehabilitation protocol. 1st/2nd Week at 35 Hertz. 3rd/4th Week 50 Hertz. 5th/6th Week 70 Hertz

Device: NMES+Procedure: Rehab

Control Group

ACTIVE COMPARATOR

The Control Group will follow the same rehabilitation protocol with no addition of the NMES+. A weight-bearing protocol with a week by week progression on load, repetitions and sets.

Procedure: Rehab

Interventions

NMES+DEVICE

The Treatment Group will follow the rehabilitation protocol with the addition of the NMES+. 1st/2nd Week at 35 Hertz. 3rd/4th Week 50 Hertz. 5th/6th Week 70 Hertz.

Treatment Group
RehabPROCEDURE

The Control Group will follow a protocol based on the latest available guidelines for the rehabilitation of the hamstrings lesions. A weight-bearing protocol with a week by week progression on load, repetitions and sets.

Control GroupTreatment Group

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • recreational or semi-professional athletes
  • Body Mass Index between 18,5 e 24,9
  • Hamstring strain lesion type 3a/3b

You may not qualify if:

  • previous hamstring strain lesions
  • Anterior Cruciate Ligament Reconstruction using Hamstring graft
  • Current hamstring strains

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Rehabilitation

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 1, 2023

First Posted

March 27, 2023

Study Start

November 1, 2023

Primary Completion

September 1, 2024

Study Completion

December 1, 2024

Last Updated

September 26, 2023

Record last verified: 2023-09